澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

RHYTHM BIOSCIENCES LTD

0.089

+0.0044.71%

成交量：29.65万

成交额：2.73万

市值：2,902.01万

市盈率：-6.26

高：0.098

开：0.092

低：0.086

收：0.085

52周最高：0.210

52周最低：0.047

股本：3.26亿

流通股本：1.88亿

量比：0.14

换手率：0.16%

股息：- -

股息率：- -

每股收益(TTM):-0.014

每股收益(LYR):-0.014

净资产收益率：-501.54%

总资产收益率：-107.16%

市净率：43.98

市盈率(LYR):-6.26

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

RHYTHM BIOSCIENCES LTD

交易所：

ASX

成立时间：

2017

员工人数：

- -

公司地址：

Bio21 Institute,30 Flemington Road,Parkville,Victoria,Australia

官网：

http://www.rhythmbio.com

邮编：

3010

电话：

传真：

61 3 9614 0550

简介：

Rhythm Biosciences Limited, a medical diagnostics technology company, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It is developing ColoSTAT, a test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Melbourne, Australia.

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/RHY.AU/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RHY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","market":"AU","secType":"STK","nameCN":"RHYTHM BIOSCIENCES LTD","latestPrice":0.089,"timestamp":1765948320000,"preClose":0.085,"halted":0,"volume":296521,"delay":0,"nameEN":"RHYTHM BIOSCIENCES LTD","floatShares":188306561,"shares":326068419,"eps":-0.014222,"marketStatus":"未开盘","change":0.004,"latestTime":"12-17 16:12:00 AEDT","open":0.092,"high":0.098,"low":0.086,"amount":27327,"amplitude":0.141176,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.014222,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1766012400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.085,"openAndCloseTimeList":[[1765926000000,1765947600000]],"volumeRatio":0.13518012009999755,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","floatShares":188306561,"roa":"-107.16%","roe":"-501.54%","lyrEps":-0.014222,"volumeRatio":0.13518012009999755,"shares":326068419,"dividePrice":0,"high":0.098,"amplitude":0.141176,"preClose":0.085,"low":0.086,"week52Low":0.047,"pbRate":"43.98","psRate":"9.09","week52High":0.21,"institutionHeld":0,"latestPrice":0.089,"eps":-0.014222,"divideRate":0,"volume":296521,"delay":0,"ttmEps":-0.014222,"open":0.092,"prevYearClose":0.087,"prevWeekClose":0.105,"prevMonthClose":0.086,"prevQuarterClose":0.083,"fiveDayClose":0.081,"twentyDayClose":0.087,"sixtyDayClose":0.089,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RHY.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-07-27","symbol":"RHY.AU","type":"split","dateTimestamp":1595772000000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":540780120,"yearFounded":2017,"address":"Bio21 Institute,30 Flemington Road,Parkville,Victoria,Australia","zipCode":"3010","officePhone":"61 3 8256 2880","officeFax":"61 3 9614 0550"},"stockCompanyDetail":{"websiteUrl":"http://www.rhythmbio.com","stockEarnings":[{"period":"1week","weight":0.0988},{"period":"1month","weight":0.0723},{"period":"3month","weight":-0.0532},{"period":"6month","weight":0.4355},{"period":"1year","weight":0.0854},{"period":"ytd","weight":0.023}],"compareEarnings":[{"period":"1week","weight":0.0158},{"period":"1month","weight":0.0034},{"period":"3month","weight":0.0407},{"period":"6month","weight":0.0797},{"period":"1year","weight":0.2277},{"period":"ytd","weight":0.2327}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Rhythm Biosciences Limited, a medical diagnostics technology company, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It is developing ColoSTAT, a test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.125,"avgChangeRate":-0.082511},{"month":2,"riseRate":0.25,"avgChangeRate":-0.101823},{"month":3,"riseRate":0.375,"avgChangeRate":0.056967},{"month":4,"riseRate":0.375,"avgChangeRate":-0.053551},{"month":5,"riseRate":0.25,"avgChangeRate":-0.061747},{"month":6,"riseRate":0.75,"avgChangeRate":0.065211},{"month":7,"riseRate":0.5,"avgChangeRate":0.069116},{"month":8,"riseRate":0.5,"avgChangeRate":0.171702},{"month":9,"riseRate":0.5,"avgChangeRate":0.03451},{"month":10,"riseRate":0.25,"avgChangeRate":0.184359},{"month":11,"riseRate":0.25,"avgChangeRate":-0.011712},{"month":12,"riseRate":0.5,"avgChangeRate":-0.00282}],"exchange":"ASX","name":"RHYTHM BIOSCIENCES LTD","nameEN":"RHYTHM BIOSCIENCES LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":null}}